InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Vanda Pharmaceuticals Inc.

VNDA Clue Score24
United States Fiscal year ends December CIK 0001347178
$4.57 +0.88% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.57 −74.77% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue146.0Operating income−18.6Net income−18.0EPS, diluted−0.41Fiscal year 2017Revenue165.1 +13.1%Operating income−16.9Net income−15.6EPS, diluted−0.35Fiscal year 2018Revenue193.1 +17.0%Operating income21.7Net income25.2EPS, diluted0.48Fiscal year 2019Revenue227.2 +17.6%Operating income22.8Net income115.6 +358.4%EPS, diluted2.11 +339.6%Fiscal year 2020Revenue248.2 +9.2%Operating income27.2Net income23.3 −79.8%EPS, diluted0.42 −80.1%Fiscal year 2021Revenue268.7 +8.3%Operating income42.2Net income33.2 +42.1%EPS, diluted0.58 +38.1%Fiscal year 2022Revenue254.4 −5.3%Operating income6.3Net income6.3 −81.1%EPS, diluted0.11 −81.0%Fiscal year 2023Revenue192.6 −24.3%Operating income−14.0Net income2.5 −60.0%EPS, diluted0.04 −63.6%Fiscal year 2024Revenue198.8 +3.2%Operating income−40.7Net income−18.9 −853.3%EPS, diluted−0.33 −925.0%Fiscal year 2025Revenue216.1 +8.7%Operating income−151.2Net income−220.5EPS, diluted−3.74
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 146.0 165.1 193.1 227.2 248.2 268.7 254.4 192.6 198.8 216.1
Growth +13.1% +17.0% +17.6% +9.2% +8.3% −5.3% −24.3% +3.2% +8.7%
Operating income −18.6 −16.9 21.7 22.8 27.2 42.2 6.3 −14.0 −40.7 −151.2
Net income −18.0 −15.6 25.2 115.6 23.3 33.2 6.3 2.5 −18.9 −220.5
Growth +358.4% −79.8% +42.1% −81.1% −60.0% −853.3%
EPS, diluted −0.41 −0.35 0.48 2.11 0.42 0.58 0.11 0.04 −0.33 −3.74
Growth +339.6% −80.1% +38.1% −81.0% −63.6% −925.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−12.7%Net margin−12.3%Free cash flow margin−6.5%Fiscal year 2017Operating margin−10.2%Net margin−9.4%Free cash flow margin−2.2%Fiscal year 2018Operating margin11.3%Net margin13.1%Free cash flow margin15.3%Fiscal year 2019Operating margin10.0%Net margin50.9%Free cash flow margin19.8%Fiscal year 2020Operating margin11.0%Net margin9.4%Free cash flow margin20.1%Fiscal year 2021Operating margin15.7%Net margin12.3%Free cash flow margin23.7%Fiscal year 2022Operating margin2.5%Net margin2.5%Free cash flow margin12.3%Fiscal year 2023Operating margin−7.2%Net margin1.3%Free cash flow margin6.4%Fiscal year 2024Operating margin−20.5%Net margin−9.5%Free cash flow margin−8.2%Fiscal year 2025Operating margin−70.0%Net margin−102.0%Free cash flow margin−51.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −12.7% −10.2% 11.3% 10.0% 11.0% 15.7% 2.5% −7.2% −20.5% −70.0%
Net margin −12.3% −9.4% 13.1% 50.9% 9.4% 12.3% 2.5% 1.3% −9.5% −102.0%
Free cash flow margin −6.5% −2.2% 15.3% 19.8% 20.1% 23.7% 12.3% 6.4% −8.2% −51.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−8.1Capital expenditure−1.4Free cash flow−9.5Fiscal year 2017Operating cash flow−2.0Capital expenditure−1.7Free cash flow−3.6Fiscal year 2018Operating cash flow30.0Capital expenditure−0.4Free cash flow29.6Fiscal year 2019Operating cash flow45.9Capital expenditure−1.0Free cash flow44.9 +51.7%Fiscal year 2020Operating cash flow51.8Capital expenditure−1.8Free cash flow50.0 +11.2%Fiscal year 2021Operating cash flow64.2Capital expenditure−0.6Free cash flow63.7 +27.4%Fiscal year 2022Operating cash flow32.0Capital expenditure−0.7Free cash flow31.3 −50.8%Fiscal year 2023Operating cash flow12.8Capital expenditure−0.4Free cash flow12.4 −60.3%Fiscal year 2024Operating cash flow−15.8Capital expenditure−0.5Free cash flow−16.2 −230.8%Fiscal year 2025Operating cash flow−109.4Capital expenditure−1.0Free cash flow−110.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −8.1 −2.0 30.0 45.9 51.8 64.2 32.0 12.8 −15.8 −109.4
Capital expenditure −1.4 −1.7 −0.4 −1.0 −1.8 −0.6 −0.7 −0.4 −0.5 −1.0
Free cash flow −9.5 −3.6 29.6 44.9 50.0 63.7 31.3 12.4 −16.2 −110.4
Growth +51.7% +11.2% +27.4% −50.8% −60.3% −230.8%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash40.4Shareholders’ equity131.3Fiscal year 2017Cash33.6Shareholders’ equity131.4Fiscal year 2018Cash61.0Shareholders’ equity275.4Fiscal year 2019Cash45.1Shareholders’ equity410.9Fiscal year 2020Cash61.0Shareholders’ equity453.3Fiscal year 2021Cash52.1Shareholders’ equity504.9Fiscal year 2022Cash135.0Shareholders’ equity527.2Fiscal year 2023Cash135.8Shareholders’ equity544.9Fiscal year 2024Cash102.3Shareholders’ equity538.5Fiscal year 2025Cash84.9Shareholders’ equity327.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 40.4 33.6 61.0 45.1 61.0 52.1 135.0 135.8 102.3 84.9
Shareholders’ equity 131.3 131.4 275.4 410.9 453.3 504.9 527.2 544.9 538.5 327.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
146.0 165.1 193.1 227.2 248.2 268.7 254.4 192.6 198.8 216.1
Growth +13.1% +17.0% +17.6% +9.2% +8.3% −5.3% −24.3% +3.2% +8.7%
29.2 38.5 43.6 48.6 55.6 75.4 85.8 76.8 74.4 109.3
99.8 123.8 105.8 129.7 140.5 124.0 136.5 112.9 146.4 238.0
−18.6 −16.9 21.7 22.8 27.2 42.2 6.3 −14.0 −40.7 −151.2
Growth +4.9% +19.4% +54.8% −85.0% −320.4%
−17.9 −15.4 25.3 29.0 31.7 42.4 11.3 6.3 −22.9 −138.6
0.1 0.1 0.1 −86.5 8.3 9.2 5.0 3.8 −4.0 81.8
−18.0 −15.6 25.2 115.6 23.3 33.2 6.3 2.5 −18.9 −220.5
Growth +358.4% −79.8% +42.1% −81.1% −60.0% −853.3%
Per share
−0.41 −0.35 0.50 2.17 0.43 0.60 0.11 0.04 −0.33 −3.74
−0.41 −0.35 0.48 2.11 0.42 0.58 0.11 0.04 −0.33 −3.74
Growth +339.6% −80.1% +38.1% −81.0% −63.6% −925.0%
43.4 44.7 50.9 53.1 54.4 55.5 56.5 57.4 58.1 58.9
43.4 44.7 53.0 54.8 55.2 56.9 57.0 57.6 58.1 58.9
Growth +3.0% +18.6% +3.4% +0.6% +3.1% +0.1% +1.0% +1.0% +1.3%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 2.7% a year over five years.
  • The diluted share count rose 6.8% in five years, which is dilution.
  • Operating margin is down 80.9 points on five years ago, at -70.0%.
  • A net loss in 4 of 10 years on file.